公开(公告)号：US20170065449A1

公开(公告)日：2017-03-09

申请号：US15123605

申请日：2015-03-03

Applicant: DMCHAIN COOPERATIVE ,  ADVANCING INC.

Inventor： Akiharu TSUCHIYA ,  Hitoshi OJIMA ,  Hidenori KASENO

IPC: A61F5/01

Abstract: Provided is a wrist joint bandage having a taping function capable of preventing tenosynovitis of the hand by reducing a burden on the wrist joint. A wrist joint bandage 100 comprises: a band-shaped main body part 10 which is woven in a fabric having a loop face 13 of a touch fastener and is composed of a winding part 11 which is wound around the wrist of a wearer, and a supporting part 12 which is disposed from the back of the hand or the palm to the wrist of the wearer; an anchor part 20 which is joined to one end 10a of the main body part 10 and into which a finger of the wearer is inserted; and an engaging part 30 which is joined to the other end 10b of the main body part 10 and has a hook face 33 of a touch fastener, which is detachably stuck to the loop face 13 of the main body part 10.

Abstract translation: 提供具有能够通过减轻腕关节负担来防止手的腱鞘炎的胶带功能的腕关节绷带。 腕关节绷带100包括：带状主体部分10，其编织在具有接触紧固件的环面13的织物中，并且由围绕佩戴者的腕部缠绕的卷绕部11组成， 支撑部分12，其从手背或手掌放置到穿戴者的腕部; 锚固部件20，其连接到主体部分10的一个端部10a，并且佩戴者的手指插入其中; 以及接合部30，其接合到主体部10的另一端10b，并且具有可拆卸地卡在主体部10的环面13上的接触紧固件的钩面33。

公开(公告)号：US20160339018A1

公开(公告)日：2016-11-24

申请号：US14362850

申请日：2014-03-03

Applicant: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION ,  KOWA COMPANY, LTD

Inventor： Tatsuro Ishibashi ,  Shintaro Nakao ,  Ryoichi Arita ,  Ken Mizuno ,  Akifumi Tsuchiura

IPC: A61K31/496 ,  A61K9/00

CPC classification number: A61K31/551 ,  A61K9/0046 ,  A61K9/0048 ,  A61K31/496 ,  A61K47/10 ,  C07D401/12

Abstract: Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.

Abstract translation: 本文公开了眼底疾病，特别是糖尿病性视网膜病变或年龄相关性黄斑变性的预防或治疗剂。 眼底疾病的预防或治疗剂包括：（S） - （ - ） - 1-（4-氟-5-异喹啉磺酰基）-2-甲基-1,4-高哌嗪，其盐或其溶剂合物， 作为活性成分。

公开(公告)号：US09489917B2

公开(公告)日：2016-11-08

申请号：US13641177

申请日：2011-04-12

Applicant: Kazuo Ichikawa ,  Kiyoshi Tanaka ,  Yoshiki Tanaka ,  Takuya Hara

Inventor： Kazuo Ichikawa ,  Kiyoshi Tanaka ,  Yoshiki Tanaka ,  Takuya Hara

IPC: G09G5/02 ,  G06T11/00 ,  A61B3/032 ,  A61B3/06

CPC classification number: G09G5/02 ,  A61B3/032 ,  A61B3/066 ,  G06T11/00

Abstract: A color perception test has a color matching processor that executes a color matching processing on a color monitor, and an image display controller that displays two or more images for color perception test in order on the color monitor on which the color matching processing was done. When displaying each image for color perception test, a color perception test is done in a state that one of its hue, brightness, saturation and display time is changed and the other elements are fixed. Since the color perception tester has the color matching processor, colors of the image are not changed with passage of time different from color printed one, and correct test can be done thereby. If the test is periodically done on some examinee, a degree of decreasing color perception function by aging can be exactly known.

Abstract translation: 颜色感知测试具有在颜色监视器上执行颜色匹配处理的颜色匹配处理器，以及在进行颜色匹配处理的彩色监视器上依次显示用于颜色感知测试的两个或更多个图像的图像显示控制器。 当显示每个图像的颜色感知测试时，颜色感知测试在其色调，亮度，饱和度和显示时间之一改变并且其他元素是固定的状态下完成。 由于颜色感知测试仪具有颜色匹配处理器，所以图像的颜色不会随着时间的推移而不同于彩色印刷，因此可以进行正确的测试。 如果在一些考生周期性地进行测试，则可以准确地知道通过老化降低颜色感知功能的程度。

公开(公告)号：US20160256470A1

公开(公告)日：2016-09-08

申请号：US15060927

申请日：2016-03-04

Applicant: KOWA COMPANY, LTD.

Inventor： Isamu SAWAI

IPC: A61K31/551 ,  A61K31/382 ,  A61K31/542 ,  A61K9/00

CPC classification number: A61K31/551 ,  A61K9/0048 ,  A61K9/08 ,  A61K31/18 ,  A61K31/382 ,  A61K31/433 ,  A61K31/542 ,  A61K45/06 ,  A61K47/02 ,  A61K2300/00

Abstract: Provided is a technology for suppressing discoloration of a halo-isoquinoline derivative-containing aqueous composition during high-temperature storage. Provided is an aqueous composition containing a compound of formula (1): wherein X is a halogen atom, a salt of the compound, or a solvate of the compound or the salt; and a carbonic anhydrase inhibitor.

Abstract translation: 提供了一种用于在高温保存期间抑制含卤代异喹啉衍生物的含水组合物变色的技术。 本发明提供含有式（1）化合物的水性组合物：其中X为卤素原子，化合物的盐或化合物或其盐的溶剂合物; 和碳酸酐酶抑制剂。

公开(公告)号：US09427314B2

公开(公告)日：2016-08-30

申请号：US14342822

申请日：2012-09-13

Applicant: Kazuharu Niwa ,  Yasuhiko Suzuki ,  Masayoshi Tanaka

Inventor： Kazuharu Niwa ,  Yasuhiko Suzuki ,  Masayoshi Tanaka

IPC: A61F2/16

CPC classification number: A61F2/167

Abstract: An intraocular lens insertion tool including: a cylindrical tool body provided with a placement part at which is placed an intraocular lens having an optical part, and a pair of support parts extending from either side of the optical part; and a plunger for pushing out the intraocular lens; the intraocular lens insertion tool being provided in a state in which the intraocular lens is preset in the placement part, wherein at least one of the front support part extending toward a tip end of the tool body and the rear support part extending toward a rear end of the tool body is pre-deformed by abutting against an abutting projection disposed inside the placement part.

Abstract translation: 一种眼内透镜插入工具，包括：圆柱形工具本体，设置有放置部，在该放置部上配置有具有光学部的眼内透镜，以及一对支撑部，从所述光学部的任一侧延伸; 以及用于推出眼内透镜的柱塞; 眼内透镜插入工具设置在预置在放置部分中的眼内透镜的状态下，其中前支撑部分中的至少一个朝向工具主体的顶端延伸，后支撑部分朝向后端延伸 通过抵靠设置在放置部内的抵接突起而被预先变形。

公开(公告)号：US20160136138A1

公开(公告)日：2016-05-19

申请号：US14903114

申请日：2014-07-09

Applicant: KOWA COMPANY, LTD.

Inventor： Haruki Shibata ,  Toshiaki Takizawa

IPC: A61K31/423

Abstract: The present invention provides a compound useful in the prevention and treatment of nonalcoholic fatty liver disease. The invention relates to a drug for the prevention and/or treatment of nonalcoholic fatty liver disease, the drug having as an active ingredient (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate of these.

Abstract translation: 本发明提供了用于预防和治疗非酒精性脂肪性肝病的化合物。 本发明涉及一种用于预防和/或治疗非酒精性脂肪肝疾病的药物，该药物具有作为活性成分的（R）-2- [3 - [[N-（苯并恶唑-2-基）-N-3 - （4-甲氧基苯氧基）丙基]氨基甲基]苯氧基]丁酸，其盐或它们的溶剂合物。

公开(公告)号：US20150313709A1

公开(公告)日：2015-11-05

申请号：US14648119

申请日：2013-11-29

Applicant: KOWA COMPANY, LTD.

Inventor： Kenichi Kobayashi

IPC: A61F2/16

CPC classification number: A61F2/167 ,  A61F2/1678

Abstract: The intraocular lens insertion tool includes a nozzle main body having a nozzle portion 15, a stage portion capable of disposing the intraocular lens 2 in the nozzle main body, and a plunger 60 that presses the intraocular lens 2 set in the stage portion by a leading end, thereby releasing the intraocular lens 2 into an eyeball. The leading end portion 10a of the nozzle portion 15 is obliquely cut so that, as it goes to the front side from the optical axis rear side of intraocular lens 2, the position of the end surface is located on the front side, and at the leading end 61d of the plunger 60, a protruding portion 61e is provided which protrudes to the front side so as to be able to place the surface of the optical axis rear side of the intraocular lens 2.

Abstract translation: 眼内透镜插入工具包括具有喷嘴部分15的喷嘴主体，能够将眼内透镜2设置在喷嘴主体中的台部，以及柱塞60，其将设置在台部中的眼内透镜2通过前端 从而将眼内透镜2释放到眼球内。 喷嘴部15的前端部10a被倾斜切割，从而当从眼内透镜2的光轴后侧向前侧移动时，端面的位置位于前侧， 柱塞60的前端61d设置有突出部61e，其突出到前侧，以能够放置眼内透镜2的光轴后侧的表面。

公开(公告)号：USD742014S1

公开(公告)日：2015-10-27

申请号：US29483212

申请日：2014-02-26

Applicant: KOWA COMPANY, LTD.

Designer： Shouta Yabe ,  Yuuki Arai ,  Naoki Kambe

公开(公告)号：US09072467B2

公开(公告)日：2015-07-07

申请号：US13138215

申请日：2009-08-26

Applicant: Takayoshi Suzuki

Inventor： Takayoshi Suzuki

IPC: H04N13/02 ,  A61B3/12 ,  A61B3/13 ,  A61B3/14

CPC classification number: A61B3/12 ,  A61B3/132 ,  A61B3/14 ,  G06T2207/10012 ,  G06T2207/30041

Abstract: A light beam reflected from an ocular fundus is split into a pair of right and left light beams by a two-aperture stop disposed in a position conjugate with an anterior ocular segment of an eye to be examined. The pair of right and left ocular fundus images having a parallax is formed as intermediate images from the split light beams at the position of a photographic mask. The optical path of the pair of ocular fundus images formed as intermediate images is split by a pair of optical path splitting lenses disposed in a position substantially conjugate with the two-aperture stop. One ocular fundus image is re-formed on half of an imaging plane of an imaging element, and the other ocular fundus image is reformed separately on the other half of the imaging plane. With such a structure, two ocular fundus images for three dimensional viewing can be efficiently obtained without using a prism for splitting the optical path.

Abstract translation: 从眼底反射的光束通过设置在与待检查的眼睛的眼前段共轭的位置的双孔径光阑分成一对左右光束。 具有视差的一对右眼和左眼眼底图像被形成为在照相掩模的位置处的分离光束的中间图像。 形成为中间图像的一对眼底图像的光路被设置在与两孔径光阑大致共轭的位置的一对光路分离透镜分开。 在成像元件的成像平面的一半上重新形成一个眼底图像，另一个眼底图像在成像平面的另一半上单独重构。 利用这种结构，可以有效地获得用于三维观察的两个眼底图像而不使用用于分割光路的棱镜。

公开(公告)号：US08996097B2

公开(公告)日：2015-03-31

申请号：US11434657

申请日：2006-05-15

Applicant: Norihiko Yokoi ,  Shigeru Kinoshita ,  Takayoshi Suzuki ,  Yutaka Mizukusa ,  Osamu Yamamoto

Inventor： Norihiko Yokoi ,  Shigeru Kinoshita ,  Takayoshi Suzuki ,  Yutaka Mizukusa ,  Osamu Yamamoto

IPC: A61B6/00 ,  A61B3/14 ,  A61B1/04 ,  A61B3/10 ,  A61B5/00 ,  G06T7/00

CPC classification number: A61B3/101 ,  A61B3/10 ,  A61B3/14 ,  A61B5/0071 ,  A61B2576/02 ,  A61M2210/0612 ,  G06T7/0014 ,  G06T2207/30041

Abstract: In an ophthalmic measuring method, a traceable marker in particulate form is administered to the lachrymal fluid of a subject's eye, and the lachrymal fluid is irradiated with illuminating light. Images of the illuminated lachrymal fluid are electronically captured respectively at different times. Two images from among the captured images are selected, with each of the two selected images displaying the traceable marker. A characteristic point of each of the two selected images is specified. A movement speed of the traceable marker is measured based on positions thereof in the two selected images and on a time difference from specifying the characteristic point of one of the two selected images to specifying the characteristic point of the other of the two selected images. The measured movement speed of the traceable marker is outputted as the movement speed of the lachrymal fluid of the subject's eye.

Abstract translation: 在眼科测定方法中，向受试者眼睛的泪液施用颗粒状的可追踪标记物，并用照射光照射泪液。 照射的泪液的图像分别在不同时间被电子捕获。 选择拍摄图像中的两个图像，其中两个所选图像中的每一个显示可追踪标记。 指定两个所选图像中的每一个的特征点。 可追踪标记的运动速度是根据两个所选图像中的位置以及与指定两个所选图像之一的特征点的指定时间差来确定两个所选图像中的另一个的特征点来测量的。 可追踪标记的测量移动速度作为受试者眼睛的泪液的移动速度输出。